A

Autifony Therapeutics

26 employees

Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Medical Device
Biotechnology
Therapeutics

Date founded

2011

Funding rounds raised

Total raised

$16M

from 7 investors over 7 rounds

A

Autifony Therapeutics raised $1.6M on March 15, 2017

Investors: The Dementia Discovery Fund and Innovate UK

A

Autifony Therapeutics raised $12M on July 10, 2015

Investors: UCL Business PLC, Imperial College London and SV Life Sciences

A

Autifony Therapeutics raised $16M on August 22, 2011

Investors: SV Life Sciences and Imperial College London

FAQ